Detalles de la búsqueda
1.
Pharmacogenetic and clinical risk factors for bevacizumab-related gastrointestinal hemorrhage in prostate cancer patients treated on CALGB 90401 (Alliance).
Pharmacogenomics J;
24(2): 6, 2024 Mar 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38438359
2.
Imaging urothelial bladder cancer: A VPAC PET targeted approach.
Can J Urol;
28(2): 10596-10602, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33872557
3.
Germline genetic testing for inherited prostate cancer in practice: Implications for genetic testing, precision therapy, and cascade testing.
Prostate;
79(4): 333-339, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30450585
4.
Prevalence and Characteristics of Patients with Suspected Inherited Renal Cell Cancer: Application of the ACMG/NSGC Genetic Referral Guidelines to Patient Cohorts.
J Genet Couns;
26(3): 548-555, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-28101821
5.
Bevacizumab and the risk of arterial and venous thromboembolism in patients with metastatic, castration-resistant prostate cancer treated on Cancer and Leukemia Group B (CALGB) 90401 (Alliance).
Cancer;
121(7): 1025-31, 2015 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25417775
6.
Xaluritamig, a STEAP1 × CD3 XmAb 2+1 Immune Therapy for Metastatic Castration-Resistant Prostate Cancer: Results from Dose Exploration in a First-in-Human Study.
Cancer Discov;
14(1): 76-89, 2024 01 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37861461
7.
Review of Cardiovascular Risk of Androgen Deprivation Therapy and the Influence of Race in Men with Prostate Cancer.
Cancers (Basel);
15(8)2023 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37190244
8.
Bispecific T-Cell Engagers Therapies in Solid Tumors: Focusing on Prostate Cancer.
Cancers (Basel);
15(5)2023 Feb 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-36900202
9.
Prostein expression on circulating tumor cells as a prognostic marker in metastatic castration-resistant prostate cancer.
Prostate Cancer Prostatic Dis;
2023 Dec 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38057610
10.
Harnessing transcriptionally driven chromosomal instability adaptation to target therapy-refractory lethal prostate cancer.
Cell Rep Med;
4(2): 100937, 2023 02 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-36787737
11.
Targeting the αVß3/NgR2 pathway in neuroendocrine prostate cancer.
Matrix Biol;
124: 49-62, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37956856
12.
Efficacy of peripheral androgen blockade in prostate cancer patients with biochemical failure after definitive local therapy: results of Cancer and Leukemia Group B (CALGB) 9782.
Cancer;
118(17): 4139-47, 2012 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-22180287
13.
Relevance of pRB Loss in Human Malignancies.
Clin Cancer Res;
28(2): 255-264, 2022 01 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34407969
14.
Accrual-Monitoring Practices for Various Disease Trials among AACI Member Cancer Centers.
Clin Pract;
12(5): 692-700, 2022 Aug 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-36136866
15.
Helix: A Digital Tool to Address Provider Needs for Prostate Cancer Genetic Testing in Clinical Practice.
Clin Genitourin Cancer;
20(2): e104-e113, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35012874
16.
STEAP1-4 (Six-Transmembrane Epithelial Antigen of the Prostate 1-4) and Their Clinical Implications for Prostate Cancer.
Cancers (Basel);
14(16)2022 Aug 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-36011027
17.
Considerations on Integrating Prostate-Specific Membrane Antigen Positron Emission Tomography Imaging Into Clinical Prostate Cancer Trials by National Clinical Trials Network Cooperative Groups.
J Clin Oncol;
40(13): 1500-1505, 2022 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35015566
18.
The NOGO receptor NgR2, a novel αVß3 integrin effector, induces neuroendocrine differentiation in prostate cancer.
Sci Rep;
12(1): 18879, 2022 11 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36344556
19.
A Novel Role for DNA-PK in Metabolism by Regulating Glycolysis in Castration-Resistant Prostate Cancer.
Clin Cancer Res;
28(7): 1446-1459, 2022 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35078861
20.
Technology-enhanced AcceleRation of Germline Evaluation for Therapy (TARGET): A randomized controlled trial of a pretest patient-driven webtool vs. genetic counseling for prostate cancer germline testing.
Contemp Clin Trials;
119: 106821, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35710085